Blog
Indiana CTSI
Indiana Clinical and Translational Sciences Institute’s mission is to increase translational biomedical research and improve the health of the people of Indiana and beyond. Indiana CTSI’s website’s main aim is to be a resource for research, education and collaboration...
Too Much, Too Fast
Many larger IRBs are under tremendous pressure to meet the demands of their clients. Some are taking on too many clients, too quickly, resulting in a stressful and rushed atmosphere. The clinical research environment has changed over the years. There is a steady...
New Whitepaper Available: Trends and Insights in IRB Warning Letters
Pearl IRB is pleased to launch it's whitepaper entitled "Trends and Insights in IRB Warning Letters." Learn all about IRB warning letters issued by the FDA, review the issues, and learn how to protect yourself from violations. Click here to download.
PRESS RELEASE: Pearl IRB brings a solution to more clinical trials in Indiana
August 2, 2010 Pearl IRB releases news about their role in fostering clinical trials in Indiana and beyond. Check out the full release, read a quote provided by Kristin Jones, President of Indiana Health Industry Forum and more. Read more.
Ethics of Safety Studies for Marketed Drugs
Ethics of Safety Studies for Marketed Drugs Even the Average Joe couldn’t have missed the discussions regarding the safety risks of Avandia. FDA is again in a tough spot and looking for answers. Traditionally, Industry was not to make safety claims about drugs, just...